| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |